申请人:——
公开号:US20030013770A1
公开(公告)日:2003-01-16
A compound of the general formula I
1
wherein
R
1
represents a substituent selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino, (C
1
-C
3
)alkyl, (C
2
-C
3
)olefinic group, (C
1
-C
3
)alkoxy, (C
1
-C
3
)alkylthio, (C
1
-C
6
)alkylamino, (C
1
-C
3
)alkoxycarbonyl, cyano, —CONH
2
, phenyl, and nitro;
R
2
represents one or more, same or different substituents selected from the group consisting of hydrogen, halogen, hydroxy, mercapto, trifluoromethyl, amino, (C
1
-C
3
)alkyl, (C
2
-C
3
)olefinic group, (C
1
-C
3
)alkoxy, (C
1
-C
3
)alkylthio, (C
1
-C
6
)alkylamino, (C
1
-C
3
)alkoxycarbonyl, cyano, —CONH
2
, phenyl, and nitro;
R
3
represents one or more, same or different substituents selected from the group consisting of hydrogen, halogen, hydroxy, mercapto, trifluoromethyl, cyano, carboxy, carbamoyl, (C
1
-C
10
)alkyl, (C
2
-C
10
)olefinic group, (C
3
-C
8
)monocyclic hydrocarbon group, (C
1
-C
10
)alkoxy, (C
1
-C
10
)alkylthio, (C
1
-C
10
)alkoxycarbonyl, and phenyl;
R
4
represents hydrogen, (C
1
-C
6
)alkyl, (C
2
-C
6
)olefinic group, or (C
3
-C
6
)monocyclic hydrocarbon group;
R
5
represents one or more, same or different substituents selected from the group consisting of hydrogen and R
1
;
X represents oxygen, sulphur, or N—OH;
and salts thereof with pharmaceutically acceptable acids, hydrates and solvates, may be used in the prophylaxis or treatment of inflammatory diseases.
一种通式为I1的化合物,其中R1代表从卤素、羟基、巯基、三
氟甲基、
氨基、(C1-C3)烷基、(C2-C3)
烯基、(C1-C3)烷
氧基、(C1-C3)烷
硫基、(C1-C6)烷基
氨基、(C1-C3)烷
氧羰基、
氰基、-CONH2、
苯基和硝基中选择的取代基;R2代表从
氢、卤素、羟基、巯基、三
氟甲基、
氨基、(C1-C3)烷基、(C2-C3)
烯基、(C1-C3)烷
氧基、(C1-C3)烷
硫基、(C1-C6)烷基
氨基、(C1-C3)烷
氧羰基、
氰基、-CONH2、
苯基和硝基中选择的一个或多个相同或不同的取代基;R3代表从
氢、卤素、羟基、巯基、三
氟甲基、
氰基、羧基、
氨基、(C1-C10)烷基、(C2-C10)
烯基、(C3-C8)单环
碳氢基团、(C1-C10)烷
氧基、(C1-C10)烷
硫基、(C1-C10)烷
氧羰基和
苯基中选择的一个或多个相同或不同的取代基;R4代表
氢、(C1-C6)烷基、(C2-C6)
烯基或(C3-C6)单环
碳氢基团;R5代表从
氢和R1中选择的一个或多个相同或不同的取代基;X代表
氧、
硫或N-OH;以及其与药学上可接受的酸盐、
水合物和溶剂化合物,可用于预防或治疗炎症性疾病。